IsoBio is a radiotherapeutic development business situated in the United States.
Isobio has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Isobio's investors include ASP Isotopes.
Isobio is headquartered in Gladwyne, United States.
IsoBio is a radiotherapeutic development business situated in the United States.
Isobio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Isobio — Funding & Investors." VCBacked, July 28, 2025, https://www.vcbacked.co/company/isobio. Accessed August 13, 2026.
VCBacked. (2025). Isobio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/isobio
{{cite web |title=Isobio — Funding & Investors |url=https://www.vcbacked.co/company/isobio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated